Lv613
2990 积分 2022-12-09 加入
Sacituzumab govitecan for Chinese patients with recurrent/metastatic cervical cancer: Interim analysis of the phase II basket study EVER-132-003
1个月前
已完结
Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
3个月前
已完结
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
7个月前
已完结
Thermophoretic glycan profiling of extracellular vesicles for triple-negative breast cancer management
7个月前
已完结
Detection of Cell Cycle Checkpoint in Drosophila by EdU Assay, BrdU Assay and Anti-Phosphorylated Histone 3 Antibody Staining
8个月前
已完结
Screening and Bioinformatics Analysis of MicroRNA Biomarkers in Triple-Negative Breast Cancer
8个月前
已关闭
Screening and Bioinformatics Analysis of MicroRNA Biomarkers in Triple-Negative Breast Cancer
8个月前
已关闭
NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling
8个月前
已完结
E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers
9个月前
已完结
19.The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment
9个月前
已完结
皖公网安备34019202002308
